The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

about

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

Item

http://www.wikidata.org/entity/Q55177523

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@en

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@nl

type

Item

label

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@en

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@nl

prefLabel

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@en

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@nl

P1476

The Differential Diagnosis and Treatment of Thrombotic Microangiopathies.

@en

P2093

Florian Kuchenbauer

http://www.w3.org/2001/XMLSchema#string

Manuela Wölfle-Guter

http://www.w3.org/2001/XMLSchema#string

Martin Bommer

http://www.w3.org/2001/XMLSchema#string

Stephan Bohl

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.

Drug-induced thrombotic microangiopathy: incidence, prevention and management.

An acute febrile pleiochromic anemia with hyaline thrombosis of the terminal arterioles and capillaries; an undescribed disease.

[Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

HIV-associated thrombotic microangiopathy in the era of highly active antiretroviral therapy: an observational study.

Ten years of pneumococcal-associated haemolytic uraemic syndrome in New Zealand children.

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.

How I treat patients with thrombotic thrombocytopenic purpura: 2010.

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura.

P304

327-334

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3238/ARZTEBL.2018.0327

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29875054

http://www.w3.org/2001/XMLSchema#string

P932

5997890

http://www.w3.org/2001/XMLSchema#string